Zhong-Gui Gan

Development and internal validation of a machine learning model for predicting second primary malignancy risk in hodgkin lymphoma survivors: a population-based competing risk analysis.

The RSF-based machine learning model accurately predicts SPM risk in HL survivors within a competing risk framework, substantially outperforming traditional regression approaches.